ArticleMultiple sclerosis journal - experimental, translational and clinical

Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC.

T Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.